TELBIVUDIN AS PROPHYLAXIS FOR HBV RECURRENCE AFTER LIVER TRANSPLANT: EFFICACY AND SAFETY

被引：0
|
作者：
Perrella, Alessandro
Pisaniello, Donatella
Ceriello, Antonio
Calise, Fulvio
Cuomo, Oreste
Lanza, Alfonso Galeota
机构：
来源：
TRANSPLANT INTERNATIONAL | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：306 / 306
页数：1
相关论文
共 50 条
  • [31] SAFETY AND EFFICACY OF PROPHYLAXIS WITH ENTECAVIR AND HEPATITIS B IMMUNOGLOBULIN IN PREVENTING HEPATITIS B RECURRENCE AFTER LIVING DONOR LIVER TRANSPLANTATION
    Ueda, Yoshihide
    Marusawa, Hiroyuki
    Kaido, Toshimi
    Ogura, Yasuhiro
    Ogawa, Kohei
    Yoshizawa, Atsushi
    Hata, Koichiro
    Chiba, Tsutomu
    Uemoto, Shinji
    HEPATOLOGY, 2011, 54 : 625A - 625A
  • [32] Commentary on "Prophylaxis against HBV recurrence after liver transplantation for HBV-related endstage liver diseases with severe hypersplenism and splenomegaly: Role of splenectomy"
    Tsoulfas, Georgios
    Agorastou, Polyxeni
    JOURNAL OF SURGICAL RESEARCH, 2013, 183 (02) : 548 - 549
  • [33] Safety and Efficacy at 4 Years in Post-Liver Transplant Patients with Chronic Kidney Disease Receiving Tenofovir Alafenamide (TAF) for HBV Prophylaxis.
    Gane, E.
    George, B.
    Ray-Chaudhuri, D.
    Mules, T.
    Holt, C. D.
    Wang, H.
    Suri, V.
    Gaggar, A.
    Osinusi, A.
    Flaherty, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 576 - 576
  • [34] HBV and HCC recurrence after LT in a single transplant center
    Rinaldo, A.
    Gambato, M.
    Ferrarese, A.
    Rupil, C.
    Zanetto, A.
    Shalaby, S.
    Germani, G.
    Senzolo, M.
    Cillo, U.
    Vitale, A.
    Boccagni, P.
    Russo, F.
    Burra, P.
    TRANSPLANTATION, 2021, 105 (08) : 145 - 145
  • [35] THE PHARMACOKINETIC PROFILE OF PASTEURIZED INTRAMUSCULAR ANTI-HBS IMMUNOGLOBULINS FOR HBV RECURRENCE PROPHYLAXIS AFTER LIVER TRANSPLANTATION
    De Simone, Paolo
    Carrai, Paola
    Franchello, Alessandro
    Salizzoni, Mauro
    Filipponi, Franco
    LIVER TRANSPLANTATION, 2008, 14 (07) : S184 - S184
  • [36] Efficacy and safety of prophylaxis with entecavir and hepatitis B immunoglobulin in preventing hepatitis B recurrence after living-donor liver transplantation
    Ueda, Yoshihide
    Marusawa, Hiroyuki
    Kaido, Toshimi
    Ogura, Yasuhiro
    Ogawa, Kohei
    Yoshizawa, Atsushi
    Hata, Koichiro
    Fujimoto, Yasuhiro
    Nishijima, Norihiro
    Chiba, Tsutomu
    Uemoto, Shinji
    HEPATOLOGY RESEARCH, 2013, 43 (01) : 67 - 71
  • [37] The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation
    Battistella, Sara
    Zanetto, Alberto
    Gambato, Martina
    Germani, Giacomo
    Senzolo, Marco
    Burra, Patrizia
    Russo, Francesco Paolo
    VIRUSES-BASEL, 2023, 15 (05):
  • [38] Nonalcoholic steatohepatitis recurrence after liver transplant
    Taneja, Sunil
    Roy, Akash
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 5
  • [39] Telbivudin May Cause Increased Polineuropathy/Myopathy in Liver Transplant Recipients
    Karasu, Zeki
    Turan, Ilker
    Duman, Soner
    Sozbilen, Murat
    Gunsar, Fulya
    Ersoz, Galip
    Akarca, Ulus
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S133 - S134
  • [40] Evaluation of efficacy and safety profile of posaconazole for prophylaxis after allogeneic haematopoietic stem cell transplant
    Silva, F.
    Vazquez, L.
    Morales, E.
    Caballero, D.
    Perez-Simon, J. A.
    Sanchez-Guijo, F.
    del Canizo, C.
    Miguel, J. San
    BONE MARROW TRANSPLANTATION, 2009, 43 : S370 - S370
12345